Chondrosarcoma treatment cost in Spain typically includes essential diagnostics like a PET-CT scan and primary surgical interventions such as bone resection, which runs from $20,000 to $35,000. For advanced cases, proton-beam therapy ranges from $25,400 to $64,700. Total expenses depend on the tumor stage and the need for reconstructive surgery, offering 40-70% savings compared to the US. Top treatment hubs include Barcelona, Madrid, and Pamplona.
Typical Chondrosarcoma Treatment Costs in Spain
Bookimed Expert Insight: Patients with complex sarcomas benefit most from multidisciplinary teams at JCI-accredited centers. Centro Médico Teknon is ideal for high-precision cases, as it features a specialized unit led by Dr. Joan Carles Galceran. For those requiring advanced radiotherapy, GenesisCare Clinics offer latest-generation external-beam options for over 15,000 patients annually. Quironsalud Madrid provides unique value through potential access to clinical trials for eligible cancer patients.
| Turkey | Austria | Spain | |
| Proton-beam therapy | from $70,000 | from $80,000 | from $25,435 |
| Proton therapy for prostate cancer | from $30,000 | from $80,000 | from $70,000 |
| Proton therapy for breast cancer | from $30,000 | from $55,000 | from $85,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Bone resection | from $12,000 | from $25,000 | from $20,000 |
Prof. Joan Carles Galceran leads the Genitourinary, CNS, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital, specializing in complex sarcoma cases.
Specialist in Orthopedic Surgery and Traumatology at Clinica Universidad de Navarra.
Dr. Luis Madero is a pediatric oncologist with 37 years of experience in treating blood disorders, bone marrow transplant, ablation therapy, and other diseases. He is a member of several associations and has extensive experience in his field.
Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.